Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
166.6 USD | +0.56% | +6.01% | -7.35% |
Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Filtration
54,4
%
| 496 | 61,9 % | 348 | 54,4 % | -29.87% |
Chromatography
19,8
%
| 132 | 16,4 % | 127 | 19,8 % | -3.84% |
Proteins
16,2
%
| 114 | 14,3 % | 103 | 16,2 % | -9.50% |
Process Analytics
8,9
%
| 54 | 6,7 % | 57 | 8,9 % | +6.18% |
Other Product
0,6
%
| 6 | 0,7 % | 4 | 0,6 % | -35.76% |
Royalty and Other
0,1
%
| 0 | 0,0 % | 0 | 0,1 % | +8.50% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
North America
44,0
%
| 345 | 43,0 % | 281 | 44,0 % | -18.45% |
Europe
37,0
%
| 297 | 37,0 % | 236 | 37,0 % | -20.31% |
APAC
19,0
%
| 160 | 20,0 % | 121 | 19,0 % | -24.29% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 01.05.14 |
Olivier Loeillot
PSD | President | 54 | 02.10.23 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 25.09.23 |
James Bylund
COO | Chief Operating Officer | 61 | 01.03.20 |
Ralf Kuriyel
CTO | Chief Tech/Sci/R&D Officer | 66 | 18.10.16 |
Sondra S. Newman
IRC | Investor Relations Contact | - | - |
Jaime Humara
SAM | Sales & Marketing | - | 01.11.22 |
Kola Otitoju
PRN | Corporate Officer/Principal | - | - |
Christine Gebski
PRN | Corporate Officer/Principal | 56 | 01.01.15 |
Vikas Gupta
PRN | Corporate Officer/Principal | - | 01.03.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 01.09.05 |
Director/Board Member | 58 | 12.06.14 | |
Martin Madaus
BRD | Director/Board Member | 64 | 06.02.23 |
Glenn Muir
BRD | Director/Board Member | 65 | 01.10.15 |
Carrie Manner
BRD | Director/Board Member | 50 | 11.06.20 |
Tony Hunt
CEO | Chief Executive Officer | 60 | 01.05.14 |
Director/Board Member | 66 | 26.05.22 | |
Rohin Mhatre
BRD | Director/Board Member | 59 | 01.03.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 55 838 548 | 52 159 662 ( 93,41 %) | 0 | 93,41 % |
Unternehmenskontakt
Repligen Corp.
41 Seyon Street Building 1, Suite 100
02453, Waltham
+781 250 0111
http://www.repligen.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Repligen Europe BV
Repligen Europe BV Medical DistributorsDistribution Services Part of Repligen Corp., Repligen Europe BV is a Dutch company that wholesales medical and dental instruments. The private company is located in Netherlands. |
Medical Distributors
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-7.35% | 9.3 Mrd. | |
-2.31% | 187 Mrd. | |
-3.20% | 106 Mrd. | |
-5.04% | 66.9 Mrd. | |
+0.20% | 49.45 Mrd. | |
+17.29% | 48 Mrd. | |
+4.06% | 40.84 Mrd. | |
+2.07% | 26.48 Mrd. | |
+2.36% | 26.25 Mrd. | |
+12.96% | 24.62 Mrd. |
- Börse
- Aktien
- 870980 Aktie
- Unternehmen Repligen Corporation